4//SEC Filing
Polsky Bruce 4
Accession 0000950170-24-076379
CIK 0001593899other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:59 PM ET
Size
9.6 KB
Accession
0000950170-24-076379
Insider Transaction Report
Form 4
Polsky Bruce
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-21+41,200→ 41,200 totalExercise: $3.44Exp: 2034-06-20→ Common Stock (41,200 underlying) - Award
Restricted Stock Units
2024-06-21+29,600→ 29,600 total→ Common Stock (29,600 underlying) - Sale
Common Stock
2024-06-20$3.49/sh−17,544$61,144→ 65,606 total
Footnotes (4)
- [F1]The shares were sold solely to cover taxes upon the vesting of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.43 to $3.53, inclusive.
- [F2]Restricted stock units convert into common stock on a one-for-one basis.
- [F3]The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
- [F4]The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 21, 2024, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.
Documents
Issuer
Atea Pharmaceuticals, Inc.
CIK 0001593899
Entity typeother
Related Parties
1- filerCIK 0001508458
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 5:59 PM ET
- Size
- 9.6 KB